RPAM
MRNA icon

Rhenman & Partners Asset Management’s Moderna MRNA Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,000
Closed -$3.1M – 91
2023
Q3 		$3.1M Sell
30,000
-15,000
-33% -$1.67M 0.33% 64
2023
Q2 		$5.47M Buy
+45,000
New +$6M 0.58% 54

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rhenman & Partners Asset Management's MRNA Position: Q4 2023 in Review

Rhenman & Partners Asset Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 30,000 shares — an estimated $3.1M sold.

Rhenman & Partners Asset Management first reported a position in MRNA in Q2 2023 and held it in 2 quarters. The position peaked at $5.47M in Q2 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Rhenman & Partners Asset Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 30,000 Moderna shares in Q4 2023, an estimated $3.1M.
  • Rhenman & Partners Asset Management first reported a position in Moderna in Q2 2023 and held it in 2 quarters.
  • Rhenman & Partners Asset Management's Moderna position peaked at $5.47M in Q2 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.